Search

Advertorials

What makes Optos a valuable gift for both you and your patients?

How Optos’ 200-degree ultra-widefield imaging can benefit your patients and your business

FOV OT 960 x 540 px
Optos

Eye care professionals who invest in Optos technology always tell us one thing – that they only wish they had done it sooner, because of the benefits to their practice and their patients*.

Optos offers the only retinal imaging technology to generate 200-degree ultra-widefield (UWF™) images in a single shot, offering insights that go far beyond conventional imaging. With up to ten** imaging modalities, Optos’ enhanced clinical insights help eye care professionals deliver the gold standard of care, while building a profitable practice.

The full modality range includes: rg colour, rgb colour, red-free, choroidal, autofluorescence green, autofluorescence blue, fluorescein angiography, indocyanine green angiography, spectral-domain optical coherence tomography (OCT) and swept-source OCT.

See the bigger picture

Choosing Optos means partnering with a leader committed to early detection and preventative eye healthcare. UWF imaging helps identify potential health issues earlier, leading to better outcomes for your patients. This proactive care approach not only benefits your patients but also builds loyalty, and contributes to a profitable and future-focused practice.

I wish optometrists knew all the benefits of having the 200-degree view. Being able to image such a large area of the retina, not just the posterior pole, has been extremely beneficial

Judith Long, optometrist, Northern Ireland

Build a more profitable practice

We understand that the upfront purchase of an Optos device can feel like a big step. However, advanced retinal imaging technology can start driving revenue in your practice the moment you invest. Clinical studies show that patients who are educated about the additional benefits of an optomap eye scan, choose to have one up to 80% of the time.2

And regardless of the size of your practice, whether a solo practitioner or part of a large multiple – various device configurations are available to suit any type of practice.

Modalities OT 1800 x 1800 px
Optos
 

Patients are benefiting from our technology, while a practice’s bottom line is increasing over time via user adoption, allowing for a significant return on the initial investment, one that can be structured to meet the specific needs of a practice.1 Purchasing an Optos device doesn’t have to feel scary, and with a range of options available and retinal imaging revenue that is scalable, practitioners are now seeing future business benefits without having to worry about the regret of hindsight.

Three ways Optos devices support a practice:

  • Develops customer loyalty
  • Supports revenue growth
  • Delivers superior clinical care.

Rosemary McWatters, an optometrist in Belfast, said: “I wish I had crunched the numbers sooner and realised it was a viable option even for a one test room, sole practitioner practice, as ultra-widefield imaging is not a gimmick but an absolutely essential piece of kit.”

Optos devices are proven to improve practice efficiencies, allowing eye care specialists to provide patient care that increases early detection, while also seeing more patients.4 Why not get Optos off your wish list, and invest in advanced retinal imaging technology that helps grow a business year-on-year?

Ready to see how Optos can transform your practice? Contact us today to schedule a no-obligation device demonstration. Discover the difference advanced retinal imaging can make for your patients – and your bottom line.

Find out more today.

References

*The endorsements featured in this marketing campaign are derived from real conversations with our current customers, reflecting their experiences with Optos products/services.

** Feature availability depends on device configuration, and may not be available in all regions. Please check with your representative.

  1. Wolfe, Optometry Times, 2021
  2. Lin, et al, Retina, 2021
  3. https://www.optos.com/globalassets/public/optos/providers/clinical-papers/css-optomap-multimodality-us.pdf
  4. Chen et al; Ophthalmology Retina, 2020.

Do you know someone who might enjoy this article?

Share it here: